Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
Condition:   Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer Interventions:   Drug: RO7515629;   Drug: tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2023 Category: Research Source Type: clinical trials